Effect of Targeted Agents on the Endocrine Response of Breast Cancer in the Neoadjuvant Setting: A Systematic Review

Inhibition of aberrantly activated pathways cross-talking with hormone receptor (HR) improves response to endocrine therapy in patients with HR-positive advanced breast cancer. We performed a Pubmed database systematic review to ascertain the existence of a better clinical response when combining en...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassadonia, Antonino, Caporale, Marta, Tinari, Nicola, Zilli, Marinella, DeTursi, Michele, Gamucci, Teresa, Vici, Patrizia, Natoli, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439944/
https://www.ncbi.nlm.nih.gov/pubmed/26000050
http://dx.doi.org/10.7150/jca.11566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439944/
https://www.ncbi.nlm.nih.gov/pubmed/26000050
http://dx.doi.org/10.7150/jca.11566

Ejemplares similares